CDMO News
Nivagen Sells MedisourceRx Unit to Hims & Hers to Fund New CDMO Facility
Nivagen Pharmaceuticals, Inc. has announced the sale of its MedisourceRx business unit to Hims & Hers Health, Inc.. The sale is part of a broader strategic plan by Nivagen to enhance its manufacturing capabilities. MedisourceRx, an FDA-registered 503B outsourcing facility,
24 September 2024